Iohexol Intermediate 5-Amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide
Iohexol/Ioversol Intermediate 5-Amino-N, N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide
Ioversol Intermediate (order based) N, N'-Bis(2,3-dihydroxypropyl)-5-(glycoloylamino)-2,4,6-triiodoisophthalamide
Iopamidol Intermediate (order based) 5-Amino-2,4,6-triiodoisophthalic acid
Iopamidol Intermediate (order based) 5-Amino-2,4,6- triiodisophthaloyl acid dichloride
Diethylenetriaminepentaacetic acid (DTPA)
2026/09/20
Recently, Beilu Pharma received the Drug Registration Certificate for Bimatoprost Ophthalmic Solution, approved and issued by the National Medical Products Administration (NMPA).
The originator of Bimatoprost Ophthalmic Solution is Allergan Inc. (USA). The product is indicated for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma andocular hypertension.

_Approved_by_NMPA_20260514140837_400x400.webp)




Call us on:
Email Us:
No.3 Shuiyuan West Road, Miyun District, Beijing, China